Addressing the distressing: Evaluating enzyme replacement therapy as a strategy to prevent malnutrition and control digestive symptoms for people with inoperable pancreatic cancer

解决令人痛苦的问题：评估酶替代疗法作为无法手术的胰腺癌患者预防营养不良和控制消化系统症状的策略

• 批准号: 458181
• 负责人: Klassen Pamela
• 金额: $ 7.65万
• 依托单位: University of Alberta
• 依托单位国家: 加拿大
• 项目类别: Studentship Programs
• 财政年份: 2021
• 资助国家: 加拿大
• 起止时间: 2021-11-01 至 2024-11-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=458181&lang=en
• 关键词: Ct Body Composition Analysis; Digestive Symptoms; Exocrine Insufficiency; Nutrition Care; Pancreatic Cancer; Pancreatic Enzyme Replacement Therapy; Patient-Oriented Research; Quality Of Life; Skeletal Muscle

Inoperable pancreatic cancer (IPC) is a terminal diagnosis with distressing symptoms including diarrhea, bloating and weight loss. Pancreatic tumors block the path of digestive enzymes, causing poor digestion and nutrient malabsorption. The resulting symp

不能手术的胰腺癌（IPC）是一种终末期诊断，伴有令人痛苦的症状，包括腹泻、腹胀和体重减轻。胰腺肿瘤阻断消化酶的通路，导致消化不良和营养吸收不良。由此产生的症状